Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander B Smith

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 15, 2026
Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the FieldMatthew J Slarve, Christine Tkaczyk, Michael P Doyle, et al.
Medrxiv : the Preprint Server for Health Sciences|August 12, 2024
Bacteriocin production facilitates nosocomial emergence of vancomycin-resistant <i>Enterococcus faecium</i>Emma G Mills, Alexander B Smith, Marissa P Griffith, et al.
Nature Microbiology|March 22, 2025
Bacteriocin production facilitates nosocomial emergence of vancomycin-resistant Enterococcus faeciumEmma G Mills, Katharine Hewlett, Alexander B Smith, et al.
Journal of Medicinal Chemistry|January 31, 2015
Discovery and profiling of a selective and efficacious Syk inhibitorGebhard Thoma, Alexander B Smith, Maurice J van Eis, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2016
Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical propertiesKlemens Hoegenauer, Nicolas Soldermann, Christina Hebach, et al.
JCI Insight|January 17, 2020
Gigaxonin glycosylation regulates intermediate filament turnover and may impact giant axonal neuropathy etiology or treatmentPo-Han Chen, Jimin Hu, Jianli Wu, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective InhibitorsKlemens Hoegenauer, Nicolas Soldermann, Frédéric Zécri, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective InhibitorsKlemens Hoegenauer, Nicolas Soldermann, Frédéric Stauffer, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2014
Syk inhibitors with high potency in presence of bloodGebhard Thoma, Joachim Blanz, Peter Bühlmayer, et al.
Mbio|December 11, 2023
Liberation of host heme by <i>Clostridioides difficile-</i>mediated damage enhances <i>Enterococcus faecalis</i> fitness during infectionAlexander B Smith, Jonathan T Specker, Katharine K Hewlett, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 15, 2026
Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the FieldMatthew J Slarve, Christine Tkaczyk, Michael P Doyle, et al.
Medrxiv : the Preprint Server for Health Sciences|August 12, 2024
Bacteriocin production facilitates nosocomial emergence of vancomycin-resistant <i>Enterococcus faecium</i>Emma G Mills, Alexander B Smith, Marissa P Griffith, et al.
Nature Microbiology|March 22, 2025
Bacteriocin production facilitates nosocomial emergence of vancomycin-resistant Enterococcus faeciumEmma G Mills, Katharine Hewlett, Alexander B Smith, et al.
Journal of Medicinal Chemistry|January 31, 2015
Discovery and profiling of a selective and efficacious Syk inhibitorGebhard Thoma, Alexander B Smith, Maurice J van Eis, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2016
Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical propertiesKlemens Hoegenauer, Nicolas Soldermann, Christina Hebach, et al.
JCI Insight|January 17, 2020
Gigaxonin glycosylation regulates intermediate filament turnover and may impact giant axonal neuropathy etiology or treatmentPo-Han Chen, Jimin Hu, Jianli Wu, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective InhibitorsKlemens Hoegenauer, Nicolas Soldermann, Frédéric Zécri, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective InhibitorsKlemens Hoegenauer, Nicolas Soldermann, Frédéric Stauffer, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2014
Syk inhibitors with high potency in presence of bloodGebhard Thoma, Joachim Blanz, Peter Bühlmayer, et al.
Mbio|December 11, 2023
Liberation of host heme by <i>Clostridioides difficile-</i>mediated damage enhances <i>Enterococcus faecalis</i> fitness during infectionAlexander B Smith, Jonathan T Specker, Katharine K Hewlett, et al.
Pageof 3